Microcirculation Evolution in Patients After Cardiac Surgery

Patients After Cardiac Surgery Clinical Trial

Official title:

Microcirculation Evolution in Patients After Cardiac Surgery

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04461743
• Other study ID #: 2020
• Status: Recruiting
• Start date: June 4, 2020
• Est. completion date: January 31, 2021

Study information

• Verified date: July 2020
• Source: Southeast University, China
• Contact: Jingyuan Xu
• Phone: 8613851417209
• Email: xujingyuanmail[@]163.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

We evaluated the impact on macrocirculatory hemodynamics and microcirculation in patients after cardiac surgery and compared the evolutions of those parameters between patients with tissue hypoperfusion and normal perfusion. Consecutive patients after cardiac surgery who required mechanical ventilation and for whom sublingual microcirculation measurements were possible enrolled.

Description:

We evaluated the impact on macrocirculatory hemodynamics and microcirculation in patients after cardiac surgery and compared the evolutions of those parameters between patients with tissue hypoperfusion and normal perfusion.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 40
• Est. completion date: January 31, 2021
• Est. primary completion date: December 31, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Consecutive patients after cardiac surgery.

• Patients whom sublingual microcirculation measurements were possible.

Exclusion Criteria:

• moribund patients

Related Conditions & MeSH terms

• Patients After Cardiac Surgery

Intervention

Other:
• No intervention
No intervention, regular therapy

Locations

Country	Name	City	State
China	Department of Critical Care Medicine	Nanjing	Jiangsu

Sponsors (1)

Lead Sponsor	Collaborator
Southeast University, China

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Microcirculation	PPV and MFI	Extubation